EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical Prospect of Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles in Kidney Disease: Challenges and the Way Forward

Maja Kosanović iD, Bojana Milutinović, Tanja J Kutzner iD, Yanis Mouloud iD, Milica Bozic iD

Pharmaceutics · 09.07.2023 · 15 (7) · 1911

DOI: 10.3390/pharmaceutics15071911 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 09.07.2023. Verfasst von Maja Kosanović und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for the Application of Nuclear Energy (INEP), University of Belgrade, 11 000 Belgrade, Serbia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Ministry of Science, Technological Development and Innovation of the Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney disease is a growing public health problem worldwide, including both acute and chronic forms. Existing therapies for kidney disease target various pathogenic mechanisms; however, these therapies only slow down the progression of the disease rather than offering a cure. One of the potential and emerging approaches for the treatment of kidney disease is mesenchymal stromal/stem cell (MSC) therapy, shown to have beneficial effects in preclinical studies. In addition, extracellular vesicles (EVs) released by MSCs became a potent cell-free therapy option in various preclinical models of kidney disease due to their regenerative, anti-inflammatory, and immunomodulatory properties. However, there are scarce clinical data available regarding the use of MSC-EVs in kidney pathologies. This review article provides an outline of the renoprotective effects of MSC-EVs in different preclinical models of kidney disease. It offers a comprehensive analysis of possible mechanisms of action of MSC-EVs with an emphasis on kidney disease. Finally, on the journey toward the implementation of MSC-EVs into clinical practice, we highlight the need to establish standardized methods for the characterization of an EV-based product and investigate the adequate dosing, safety, and efficacy of MSC-EVs application, as well as the development of suitable potency assays.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injurycell-free therapeuticschronic kidney diseaseclinical applicationextracellular vesicleskidney diseasemechanism of actionmesenchymal stromal/stem cellsrenoprotectiontransplantation

Autor:innen und Institutionen

  • Institute for the Application of Nuclear Energy (INEP), University of Belgrade, 11 000 Belgrade, Serbia.
  • Department of Neurosurgery, MD Anderson Cancer Center, University of Texas, Houston, TX 770302, USA.
  • Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, 45355 Essen, North Rhine-Westhpalia, Germany.
  • Vascular and Renal Translational Research Group, Biomedical Research Institute of Lleida Dr. Pifarré Foundation (IRBLLEIDA), 25196 Lleida, Spain.

ORCID-Profile: Maja Kosanović, Tanja J Kutzner, Yanis Mouloud, Milica Bozic

Förderung

  • Instituto de Salud Carlos III
  • Ministry of Science, Technological Development and Innovation of the Republic of Serbia

Zitieren

APA

Kosanović, M., Milutinović, B., Kutzner, T. J., Mouloud, Y., & Bozic, M. (2023). Clinical Prospect of Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles in Kidney Disease: Challenges and the Way Forward. Pharmaceutics, 15(7), 1911. https://doi.org/10.3390/pharmaceutics15071911

Vancouver

Kosanović M, Milutinović B, Kutzner TJ, Mouloud Y, Bozic M. Clinical Prospect of Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles in Kidney Disease: Challenges and the Way Forward. Pharmaceutics. 2023;15(7):1911. doi:10.3390/pharmaceutics15071911

BibTeX
@article{Kosanovi2023,
  author = {Kosanović, Maja and Milutinović, Bojana and Kutzner, Tanja J and Mouloud, Yanis and Bozic, Milica},
  title = {Clinical Prospect of Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles in Kidney Disease: Challenges and the Way Forward},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {7},
  pages = {1911},
  doi = {10.3390/pharmaceutics15071911}
}
Kostenlos starten →